Using cisplatin, which is a chemotherapeutic agent that induces apoptosis and one of the most common treatments for esophageal cancer, cell experiments were performed to determine the presence of a difference in the response to the drug between cells overexpressing GCH1 and esophageal cancer cells in which GCH1 was knocked down. The gene discussed is GCH1; the disease is esophageal cancer.